PlainRecalls
FDA Drug Moderate Class II Terminated

Rifampin Capsules USP, 300 mg, 100 Capsules (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 60687-586-01 (Individual Dose NDC: 60687-586-11)

Reported: January 25, 2023 Initiated: December 20, 2022 #D-0165-2023

Product Description

Rifampin Capsules USP, 300 mg, 100 Capsules (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 60687-586-01 (Individual Dose NDC: 60687-586-11)

Reason for Recall

Failed Impurities/Degradations Specifications

Details

Units Affected
3,091 cartons
Distribution
Nationwide in the USA.
Location
Columbus, OH

Frequently Asked Questions

What product was recalled?
Rifampin Capsules USP, 300 mg, 100 Capsules (10 x 10) per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 60687-586-01 (Individual Dose NDC: 60687-586-11). Recalled by Amerisource Health Services LLC. Units affected: 3,091 cartons.
Why was this product recalled?
Failed Impurities/Degradations Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on January 25, 2023. Severity: Moderate. Recall number: D-0165-2023.